European Leukemia Net

European LeukemiaNet 2017 AML recommendations: impact on risk stratification and survival VJHemOnc – Video Journal of Hematology & HemOnc 165 5 лет назад
AML diagnosis and treatment 2022 Stanley Kim 15,247 2 года назад
MRD in AML: ELN recommendations VJHemOnc – Video Journal of Hematology & HemOnc 146 4 года назад
The standardization of flow cytometry VJHemOnc – Video Journal of Hematology & HemOnc 185 7 лет назад
AML risk stratification VJHemOnc – Video Journal of Hematology & HemOnc 366 2 года назад
Updates in the diagnosis, risk stratification & treatment of AML: WHO, ICC, and ELN classifications VJHemOnc – Video Journal of Hematology & HemOnc 442 1 год назад
Minimal residual disease (MRD) as a prognostic factor for acute myeloid leukemia (AML) VJHemOnc – Video Journal of Hematology & HemOnc 718 7 лет назад
Challenges with measurable residual disease (MRD) assessment in acute myeloid leukemia (AML) VJHemOnc – Video Journal of Hematology & HemOnc 87 7 лет назад
Predicting the outcomes of patients with AML treated with CPX-351 based on ELN risk stratification VJHemOnc – Video Journal of Hematology & HemOnc 61 2 года назад
Pregnancy outcomes in CML patients VJHemOnc – Video Journal of Hematology & HemOnc 1,208 5 лет назад
Impact of MMRD and ELN genetic classification in outcomes for patients with AML underoging alloHCT VJHemOnc – Video Journal of Hematology & HemOnc 104 3 года назад
The AML Global Portal AML Hub 72 6 лет назад
Is there a need to change AML risk stratification? AML Hub 128 4 года назад
Novel classification system to improve post-transplant AML prognosis VJHemOnc – Video Journal of Hematology & HemOnc 61 3 года назад
Validation of 2022 diagnostic & prognostic classifications of AML VJHemOnc – Video Journal of Hematology & HemOnc 120 1 год назад